Huons Global Co., Ltd. (KOSDAQ:084110)

South Korea flag South Korea · Delayed Price · Currency is KRW
53,200
-2,100 (-3.80%)
Oct 30, 2025, 3:30 PM KST
-3.80%
Market Cap647.98B
Revenue (ttm)813.69B
Net Income (ttm)16.24B
Shares Out12.18M
EPS (ttm)1,332.95
PE Ratio39.91
Forward PEn/a
Dividend260.00 (0.47%)
Ex-Dividend DateAug 20, 2025
Volume66,584
Average Volume106,887
Open55,600
Previous Close55,300
Day's Range53,100 - 56,700
52-Week Range27,600 - 60,600
Beta0.99
RSI53.09
Earnings DateNov 12, 2025

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami... [Read more]

Sector Healthcare
Founded 1965
Employees 118
Stock Exchange KOSDAQ
Ticker Symbol 084110
Full Company Profile

Financial Performance

In 2024, Huons Global's revenue was 813.46 billion, an increase of 7.26% compared to the previous year's 758.38 billion. Earnings were 25.79 billion, a decrease of -32.81%.

Financial Statements

News

There is no news available yet.